search
Back to results

Postoperative Systemic Corticosteroids When Utilizing a Steroid-Eluting Spacer Following Endoscopic Sinus Surgery

Primary Purpose

Chronic Sinusitis, Endoscopic Sinus Surgery, Post-operative Care

Status
Completed
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Steroid-eluting middle meatal spacer (Nasopore (TM) spacer impregnated with 1 cc of 40mg/mL triamcinolone liquid)
Post-op Oral Steroids
Sponsored by
University of Calgary
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Chronic Sinusitis

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Adult ( > 18 years of age)
  • CRS defined by 2007 Adult Sinusitis Guidelines19
  • Electing endoscopic sinus surgery for the indication medically refractory CRS, as defined by having persistent symptoms despite the following "maximal medical therapy":

    1. Received 3 months of topical corticosteroid spray
    2. Received a 2 week course of a broad-spectrum antibiotic combined with a 2 week course of systemic corticosteroid
  • Provide written informed consent
  • Subject must be able to complete all study evaluations and HRQoL questionnaires written in English

Exclusion Criteria:

  • Children (< 18 years of age)
  • Unable to complete questionnaires or clinical testing or cooperate with study evaluations in English.
  • Unwilling to provide written, informed consent
  • Patients who have not undergone previous "maximum" prescribed medical therapy
  • Patients with suspected systemic inflammatory disease

Sites / Locations

  • Richmond Road Diagnostic and Treatment Centre

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Systemic Steroid Group

Placebo

Arm Description

Will receive post-operative oral steroids for 10 days as per usual protocol.

Will receive placebo pills for 10 days post-operatively

Outcomes

Primary Outcome Measures

Health Related Quality of Life Score (based on SNOT-22, VAS, and RSDI questionnaires)
Do systemic steroids following sinus surgery improve surgical results in patients where a steroid-eluting nasal spacer is placed at the completion of surgery. This will be based on validated chronic sinusitis-symptom specific HRQOL questionnaires (SNOT-22, VAS, RSDI)and mucosal disease grading scores via endoscopic examination (POSE, Lund-Kennedy).

Secondary Outcome Measures

Sinus mucosal disease endoscopic grading score (based on Lund-Kennedy and POSE Scoring systems)
Do systemic steroids following sinus surgery improve surgical results in patients where a steroid-eluting nasal spacer is placed at the completion of surgery. This will be based on validated mucosal disease grading scores via endoscopic examination (POSE, Lund-Kennedy).

Full Information

First Posted
March 22, 2012
Last Updated
December 1, 2014
Sponsor
University of Calgary
search

1. Study Identification

Unique Protocol Identification Number
NCT01564355
Brief Title
Postoperative Systemic Corticosteroids When Utilizing a Steroid-Eluting Spacer Following Endoscopic Sinus Surgery
Official Title
The Role of Postoperative Systemic Corticosteroids When Utilizing a Steroid-Eluting Middle Meatal Spacer Following Endoscopic Sinus Surgery: A Randomized, Double-Blind, Placebo Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
December 2014
Overall Recruitment Status
Completed
Study Start Date
April 2012 (undefined)
Primary Completion Date
September 2013 (Actual)
Study Completion Date
December 2013 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Calgary

4. Oversight

5. Study Description

Brief Summary
Chronic rhinosinusitis (CRS) is an inflammatory condition of the nose and sinuses. It affects about 5 to 10% of Canadians. Patients suffer from congestion in the nose and sinuses, nasal discharge, pressure in the face, and a reduced sense of smell. This affects people's enjoyment of life. Medical management uses sprays or pills to treat these symptoms but for some patients sinus surgery is needed. This type of surgery is called endoscopic sinus surgery (ESS). There is no single correct approach to take care of patients after sinus surgery. Most experts would use a nasal spray and a short-course of oral steroid pills to reduce sinus swelling and minimize complications related to scarring. "Steroid-eluting nasal spacers" are devices placed inside the sinus during surgery and slowly release topical steroids into the sinuses better than steroid sprays. These "spacers" have been shown to improve results following sinus surgery. When using these special "spacers", there may no longer be a need for oral steroid pills following surgery. This would help to avoid potential side effects associated with these medications. The purpose of this study is to find out whether taking oral (systemic) steroid pills following sinus surgery is necessary to improve surgical results, now that steroid-eluting nasal spacers are commonly used during surgery.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Sinusitis, Endoscopic Sinus Surgery, Post-operative Care, Steroids, Drug-eluting Spacer

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
80 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Systemic Steroid Group
Arm Type
Experimental
Arm Description
Will receive post-operative oral steroids for 10 days as per usual protocol.
Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
Will receive placebo pills for 10 days post-operatively
Intervention Type
Device
Intervention Name(s)
Steroid-eluting middle meatal spacer (Nasopore (TM) spacer impregnated with 1 cc of 40mg/mL triamcinolone liquid)
Intervention Description
All study arms will receive bilateral Nasopore spacers impregnated with 1 cc of Triamcinolone to remain in the nasal cavity for 1 week post-operatively as per usual protocol.
Intervention Type
Drug
Intervention Name(s)
Post-op Oral Steroids
Intervention Description
Post-operative oral prednisone 20 mg QD x 5 days , then 10 mg x 5 days, as per usual protocol.
Primary Outcome Measure Information:
Title
Health Related Quality of Life Score (based on SNOT-22, VAS, and RSDI questionnaires)
Description
Do systemic steroids following sinus surgery improve surgical results in patients where a steroid-eluting nasal spacer is placed at the completion of surgery. This will be based on validated chronic sinusitis-symptom specific HRQOL questionnaires (SNOT-22, VAS, RSDI)and mucosal disease grading scores via endoscopic examination (POSE, Lund-Kennedy).
Time Frame
Up to 2 years
Secondary Outcome Measure Information:
Title
Sinus mucosal disease endoscopic grading score (based on Lund-Kennedy and POSE Scoring systems)
Description
Do systemic steroids following sinus surgery improve surgical results in patients where a steroid-eluting nasal spacer is placed at the completion of surgery. This will be based on validated mucosal disease grading scores via endoscopic examination (POSE, Lund-Kennedy).
Time Frame
Up to 3 years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Adult ( > 18 years of age) CRS defined by 2007 Adult Sinusitis Guidelines19 Electing endoscopic sinus surgery for the indication medically refractory CRS, as defined by having persistent symptoms despite the following "maximal medical therapy": Received 3 months of topical corticosteroid spray Received a 2 week course of a broad-spectrum antibiotic combined with a 2 week course of systemic corticosteroid Provide written informed consent Subject must be able to complete all study evaluations and HRQoL questionnaires written in English Exclusion Criteria: Children (< 18 years of age) Unable to complete questionnaires or clinical testing or cooperate with study evaluations in English. Unwilling to provide written, informed consent Patients who have not undergone previous "maximum" prescribed medical therapy Patients with suspected systemic inflammatory disease
Facility Information:
Facility Name
Richmond Road Diagnostic and Treatment Centre
City
Calgary
State/Province
Alberta
ZIP/Postal Code
T2T 5C7
Country
Canada

12. IPD Sharing Statement

Citations:
PubMed Identifier
24482348
Citation
Dautremont JF, Mechor B, Rudmik L. The role of immediate postoperative systemic corticosteroids when utilizing a steroid-eluting spacer following sinus surgery. Otolaryngol Head Neck Surg. 2014 Apr;150(4):689-95. doi: 10.1177/0194599814521373. Epub 2014 Jan 30.
Results Reference
derived

Learn more about this trial

Postoperative Systemic Corticosteroids When Utilizing a Steroid-Eluting Spacer Following Endoscopic Sinus Surgery

We'll reach out to this number within 24 hrs